Vishnu V Chundi
Overview
Explore the profile of Vishnu V Chundi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
4
Citations
45
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Han A, Rodriguez T, Beck E, Relich R, Udeoji D, Petrak R, et al.
Curr Probl Cancer Case Rep
. 2021 Jul;
3:100057.
PMID: 34308401
The coronavirus disease 19 (COVID-19) pandemic has infected tens of millions across the world, but there is a significant gap in our understanding about COVID-19 in the hematopoietic stem transplant...
2.
Sohal S, Rodriguez-Nava G, Khabbaz R, Chaudry S, Musurakis C, Chitrakar S, et al.
Case Rep Infect Dis
. 2020 Oct;
2020:8882348.
PMID: 33014484
COVID-19 infection caused by SARS-CoV2 virus is an acute respiratory illness which was declared as a pandemic by the World Health Organization. Usually, SARS-CoV2 infects independently and can cause spectrum...
3.
Petrak R, Skorodin N, Van Hise N, Fliegelman R, Pinsky J, Didwania V, et al.
Clin Transl Sci
. 2020 Sep;
14(6):2146-2151.
PMID: 32918792
Tocilizumab is an IL-6 receptor antagonist with the ability to suppress the cytokine storm in critically ill patients infected with severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2). We evaluated patients treated...
4.
Petrak R, Skorodin N, Fliegelman R, Hines D, Chundi V, Harting B
Open Forum Infect Dis
. 2016 Nov;
3(4):ofw193.
PMID: 27807591
Outpatient parenteral antibiotic therapy (OPAT) is a safe and effective modality for treating serious infections. This study was undertaken to define the value of OPAT in a multicentered infectious disease...